Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

David M. Fleischer, Hugh A. Sampson, Peter Smith et al.|Journal of Allergy and Clinical Immunology|2020

Cited by 101